486
Views
3
CrossRef citations to date
0
Altmetric
Articles

A Study of the Frequency and Social Determinants of Exposure to Cancer-Related Direct-to-Consumer Advertising Among Breast, Prostate, and Colorectal Cancer Patients

REFERENCES

  • Abel, G. A., Burstein, H. J., Hevelone, N. D., & Weeks, J. C. (2009). Cancer-related direct-to-consumer advertising: Awareness, perceptions, and reported impact among patients undergoing active cancer treatment. Journal of Clinical Oncology, 27, 4182–4187.
  • Abel, G. A., Chen, K., Taback, N., Hassett, M. J., Schrag, D., & Weeks, J. C. (2013). Impact of oncology-related direct-to-consumer advertising. Cancer, 119, 1065–1072.
  • Abel, G. A., Lee, S. J., & Weeks, J. C. (2007). Direct-to-consumer advertising in oncology: A content analysis of print media. Journal of Clinical Oncology, 25, 1267–1271.
  • Abernathy, L. T., & Adams-Price, C. E. (2006). Memory and comprehension of magazine-based prescription drug advertisements among young and old adults. Journal of Current Issues & Research in Advertising, 28, 1–13.
  • Aikin, K. J., Swasy, J. L., & Braman, A. C. (2004). Patient and physician attitudes and behaviors associated with DTC promotion of prescription drugs—Summary of FDA survey research results. Washington, DC: U.S. Food and Drug Administration. Retrieved from http://www.fda.gov/downloads/Drugs/ScienceResearch/ResearchAreas/DrugMarketingAdvertisingandCommunicationsResearch/UCM152860.pdf
  • Alperstein, N. M., & Peyrot, M. (1993). Consumer awareness of prescription drug advertising. Journal of Advertising Research, 33, 50–56.
  • American Association for Public Opinion Research. (2006). Standard definitions: Final dispositions of case codes and outcome rates for surveys. Lenexa, KS: AAPOR.
  • American Cancer Society. (2013). Cancer facts and figures  2013. Atlanta, GA. Retrieved from http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf
  • American Medical Association. (2006, February 27). Hospital ad spending rising—amednews.com. Retrieved from http://www.ama-assn.org/amednews/2006/02/27/bicb0227.htm
  • Ball, J. G., Manika, D., & Stout, P. (2011). Consumers young and old: Segmenting the target markets for direct-to-consumer prescription drug advertising. Health Marketing Quarterly, 28, 337–353.
  • Bell, R. A., Kravitz, R. L., & Wilkes, M. S. (1999). Direct‐to‐consumer prescription drug advertising and the public. Journal of General Internal Medicine, 14, 651–657.
  • Bell, R. A., Kravitz, R. L., & Wilkes, M. S. (2000). Direct-to-consumer prescription drug advertising, 1989–1998. A content analysis of conditions, targets, inducements, and appeals. Journal of Family Practice, 49, 329–335.
  • Beltramini, R. F. (2010). DTC advertising’s programmatic research and its effect on health communication. Health Communication, 25, 574–575.
  • Chao, B. A. (2005). Evaluating the educational content of direct-to-consumer fulfillment materials. American Journal of Health-System Pharmacy, 62, 620–625.
  • Crawley, L. M., Hisaw, L., & Illes, J. (2009). Direct-to-consumer advertising in black and white: Racial differences in placement patterns of print advertisements for health products and messages. Health Marketing Quarterly, 26, 279–292.
  • Dillman, D. A., & Dillman, D. A. (2000). Mail and Internet surveys: The tailored design method (2nd ed.). New York, NY: J. Wiley.
  • Duerksen, S. C., Mikail, A., Tom, L., Patton, A., Lopez, J., Amador, X., … Sadler, G. R. (2005). Health disparities and advertising content of women’s magazines: A cross-sectional study. BMC Public Health, 5, 85.
  • Enders, C. K., & Bandalos, D. L. (2001). The relative performance of full information maximum likelihood estimation for missing data in structural equation models. Structural Equation Modeling, 8, 430–457.
  • Frank, R. G., Berndt, E. R., Donohue, J., Epstein, A., & Rosenthal, M. (2002). Trends in direct-to-consumer advertising of prescription drugs. Henry J. Kaiser Family Foundation. Retrieved from http://www.kff.org/rxdrugs/loader.cfm?url=/commonspot/security/getfile.cfm&PageID=14881
  • Gray, S. W., & Abel, G. A. (2012). Update on direct-to-consumer marketing in oncology. Journal of Oncology Practice, 8, 124–127.
  • Greene, F. L., Page, D. L., Fleming, I. D., Fritz, A., Balch, C. M., Haller, D. G., & Morrow, M. (Eds.). (2002). AJCC cancer staging manual (6th ed.). New York, NY: Springer-Verlag.
  • Gross, C. P., Smith, B. D., Wolf, E., & Andersen, M. (2008). Racial disparities in cancer therapy. Cancer, 112, 900–908.
  • Illes, J., Kann, D., Karetsky, K., Letourneau, P., Raffin, T. A., Schraedley-Desmond, P., … Atlas, S. W. (2004). Advertising, patient decision making, and self-referral for computed tomographic and magnetic resonance imaging. Archives of Internal Medicine, 164, 2415–2419.
  • Joseph, M., Stone, G., Haper, J., Stockwell, E., Johnson, K., & Huckaby, J. (2005). The effect of manufacturer-to-consumer prescription drug advertisements: An exploratory investigation. Journal of Medical Marketing, 5, 233–244.
  • Kaphingst, K. A., & DeJong, W. (2004). The educational potential of direct-to-consumer prescription drug advertising. Health Affairs, 23, 143–150.
  • Kaphingst, K. A., Rudd, R. E., DeJong, W., & Daltroy, L. H. (2004). Literacy demands of product information intended to supplement television direct-to-consumer prescription drug advertisements. Patient Education and Counseling, 55, 293–300.
  • Kaphingst, K. A., Rudd, R. E., DeJong, W., & Daltroy, L. H. (2005). Comprehension of information in three direct-to-consumer television prescription drug advertisements among adults with limited literacy. Journal of Health Communication, 10, 609–619.
  • Kelly, B. J., Fraze, T. K., & Hornik, R. C. (2010). Response rates to a mailed survey of a representative sample of cancer patients randomly drawn from the Pennsylvania Cancer Registry: A randomized trial of incentive and length effects. BMC Medical Research Methodology, 10, 65.
  • Kontos, E. Z., Emmons, K. M., Puleo, E., & Viswanath, K. (2010). Communication inequalities and public health implications of adult social networking site use in the United States. Journal of Health Communication, 15( Suppl. 3), 216–235.
  • Kontos, E. Z., & Viswanath, K. (2011). Cancer-related direct-to-consumer advertising: A critical review. Nature Reviews Cancer, 11, 142–150.
  • Kornfield, R., Donohue, J., Berndt, E. R., & Alexander, G. C. (2013). Promotion of prescription drugs to consumers and providers, 2001–2010. PLoS One, 8, e55504.
  • Lee, D., & Begley, C. E. (2010). Racial and ethnic disparities in response to direct-to-consumer advertising. American Journal of Health-System Pharmacy, 67, 1185–1190.
  • Lovett, K. M., & Liang, B. A. (2011). Risks of online advertisement of direct-to-consumer thermography for breast cancer screening. Nature Reviews Cancer, 11, 827–828.
  • Murray, E., Lo, B., Pollack, L., Donelan, K., & Lee, K. (2004). Direct-to-consumer advertising: Public perceptions of its effects on health behaviors, health care, and the doctor–patient relationship. Journal of the American Board of Family Practice, 17, 6–18.
  • National Cancer Institute. (2013). Drugs approved for breast cancer. Retrieved from http://www.cancer.gov/cancertopics/druginfo/breastcancer
  • Niederdeppe, J. (2008). Beyond knowledge gaps: Examining socioeconomic differences in response to cancer news. Human Communication Research, 34, 423–447.
  • Omonuwa, S. C. (2001). Health disparity in black women: Lack of pharmaceutical advertising in black vs. white-oriented magazines. Journal of the National Medical Association, 93, 263–266.
  • Ramanadhan, S., & Viswanath, K. (2006). Health and the information nonseeker: A profile. Health Communication, 20, 131–139.
  • Southwell, B. G., Barmada, C. H., Hornik, R. C., & Maklan, D. M. (2002). Can we measure encoded exposure? Validation evidence from a national campaign. Journal of Health Communication, 7, 445–453.
  • Southwell, B. G., & Langteau, R. (2008). Age, memory changes, and the varying utility of recognition as a media effects pathway. Communication Methods and Measures, 2, 100–114.
  • Tan, A. S. L., & Hornik, R. C. (2014). Measuring exposure to direct-to-consumer advertising: A validation study in the context of cancer-related treatment advertising. Communication Methods and Measures, 8, 52–78.
  • Ward, E., Jemal, A., Cokkinides, V., Singh, G. K., Cardinez, C., Ghafoor, A., & Thun, M. (2004). Cancer disparities by race/ethnicity and socioeconomic status. CA: A Cancer Journal for Clinicians, 54, 78–93.
  • Weaver, K. E., Rowland, J. H., Bellizzi, K. M., & Aziz, N. M. (2010). Forgoing medical care because of cost. Cancer, 116, 3493–3504.
  • Wilkes, M. S., Bell, R. A., & Kravitz, R. L. (2000). Direct-to-consumer prescription drug advertising: Trends, impact, and implications. Health Affairs, 19, 110–128.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.